267 related articles for article (PubMed ID: 15833507)
1. Impact of lymphadenectomy and nodal burden in renal cell carcinoma: retrospective analysis of the National Surveillance, Epidemiology, and End Results database.
Joslyn SA; Sirintrapun SJ; Konety BR
Urology; 2005 Apr; 65(4):675-80. PubMed ID: 15833507
[TBL] [Abstract][Full Text] [Related]
2. Value of frozen section analysis of enlarged lymph nodes during radical nephrectomy for renal cell carcinoma.
Ming X; Ningshu L; Hanzhong L; Zhongming H; Tonghua L
Urology; 2009 Aug; 74(2):364-8. PubMed ID: 19362343
[TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.
Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz BJ; Figlin RA; Belldegrun AS
J Urol; 2003 Jun; 169(6):2076-83. PubMed ID: 12771723
[TBL] [Abstract][Full Text] [Related]
4. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
Wright JL; Lin DW; Porter MP
Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic lymph node dissection in clinically node-negative patients undergoing laparoscopic nephrectomy for renal carcinoma.
Chapman TN; Sharma S; Zhang S; Wong MK; Kim HL
Urology; 2008 Feb; 71(2):287-91. PubMed ID: 18308105
[TBL] [Abstract][Full Text] [Related]
6. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract.
Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K
J Urol; 2007 Oct; 178(4 Pt 1):1212-7; discussion 1217. PubMed ID: 17698147
[TBL] [Abstract][Full Text] [Related]
7. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base.
Konety BR; Joslyn SA; O'Donnell MA
J Urol; 2003 Mar; 169(3):946-50. PubMed ID: 12576819
[TBL] [Abstract][Full Text] [Related]
8. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.
Canfield SE; Kamat AM; Sánchez-Ortiz RF; Detry M; Swanson DA; Wood CG
J Urol; 2006 Mar; 175(3 Pt 1):864-9. PubMed ID: 16469567
[TBL] [Abstract][Full Text] [Related]
9. Lymph node involvement in renal cell carcinoma and survival chance by systematic lymphadenectomy.
Schafhauser W; Ebert A; Brod J; Petsch S; Schrott KM
Anticancer Res; 1999; 19(2C):1573-8. PubMed ID: 10365148
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy.
Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz B; Belldegrun AS; Figlin RA
Cancer; 2003 Jun; 97(12):2995-3002. PubMed ID: 12784334
[TBL] [Abstract][Full Text] [Related]
11. Effect of axillary lymphadenectomy on breast carcinoma survival.
Joslyn SA; Konety BR
Breast Cancer Res Treat; 2005 May; 91(1):11-8. PubMed ID: 15868427
[TBL] [Abstract][Full Text] [Related]
12. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma.
Blute ML; Leibovich BC; Cheville JC; Lohse CM; Zincke H
J Urol; 2004 Aug; 172(2):465-9. PubMed ID: 15247704
[TBL] [Abstract][Full Text] [Related]
13. Reassessing the current TNM lymph node staging for renal cell carcinoma.
Terrone C; Cracco C; Porpiglia F; Bollito E; Scoffone C; Poggio M; Berruti A; Ragni F; Cossu M; Scarpa RM; Rossetti SR
Eur Urol; 2006 Feb; 49(2):324-31. PubMed ID: 16386352
[TBL] [Abstract][Full Text] [Related]
14. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.
Margulis V; Tamboli P; Matin SF; Swanson DA; Wood CG
Cancer; 2008 Apr; 112(7):1480-8. PubMed ID: 18240184
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective.
Lughezzani G; Capitanio U; Jeldres C; Isbarn H; Shariat SF; Arjane P; Widmer H; Perrotte P; Montorsi F; Karakiewicz PI
Cancer; 2009 Dec; 115(24):5680-7. PubMed ID: 19824083
[TBL] [Abstract][Full Text] [Related]
16. Effect of nodal metastases on cancer-specific mortality after cytoreductive nephrectomy.
Trinh QD; Sukumar S; Schmitges J; Bianchi M; Sun M; Shariat SF; Sammon JD; Jeldres C; Zorn KC; Perrotte P; Graefen M; Rogers CG; Peabody JO; Menon M; Karakiewicz PI
Ann Surg Oncol; 2013 Jun; 20(6):2096-102. PubMed ID: 23263779
[TBL] [Abstract][Full Text] [Related]
17. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).
Capitanio U; Suardi N; Matloob R; Roscigno M; Abdollah F; Di Trapani E; Moschini M; Gallina A; Salonia A; Briganti A; Montorsi F; Bertini R
BJU Int; 2014 Aug; 114(2):210-5. PubMed ID: 24854206
[TBL] [Abstract][Full Text] [Related]
18. Role of lymphadenectomy in renal cell carcinoma.
Ditonno P; Traficante A; Battaglia M; Grossi FS; Selvaggi FP
Prog Clin Biol Res; 1992; 378():169-74. PubMed ID: 1301578
[TBL] [Abstract][Full Text] [Related]
19. Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma).
Capitanio U; Perrotte P; Zini L; Jeldres C; Shariat SF; Isbarn H; Arjane P; Peloquin F; Pharand D; Montorsi F; Karakiewicz PI
BJU Int; 2009 Sep; 104(6):795-9. PubMed ID: 19389018
[TBL] [Abstract][Full Text] [Related]
20. [Transabdominal radical nephrectomy for renal cell carcinoma: an experience on 155 patients].
Chen XF; Zhou FJ; Han H; Qin ZK; Liu ZW; Yu SL; Li YH; Wang H; Hou GL
Ai Zheng; 2007 May; 26(5):528-32. PubMed ID: 17672946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]